Skip to content
DraconiticResearch
Search Sources API
194,161 studies31 sourcesUpdated 21 min ago
Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer

749 Reprogramming of macrophage Fc receptor expression and antibody handling by cachexia-associated tumor secretory factors

  • Latha Ganesan1
  • Adeoluwa Adeluola2
  • Aki Inase3
  • Gregory M Young4
  • Juehui Mao4
  • Thomas A Mace5
  • Dwight H Owen6
  • Christopher C Coss4
  • Mitch A Phelps7
7 affiliations
  1. 1The Ohio State University Division of Rheumatology and Immunology, Columbus, OH, USA
  2. 21The Ohio State University, Columbus, OH, USA
  3. 31The Ohio State University College of Pharmacy, Columbus, OH, USA
  4. 4The Ohio State University College of Pharmacy, Columbus, OH, USA
  5. 5The Ohio State University Division of Gastroenterology, Columbus, OH, USA
  6. 6The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA
  7. 7The Ohio State University, Columbus, OH, USA
Open at sourcePDFDOICite

Related

  1. Tumor-associated macrophage reprogramming in cancer: recent advances in resistance mechanisms and therapy
    Abdullah Farhan Saeed, Muhammad Naim Ashraf, Muhammad Zaheer Iqbal
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyCrossref
  2. Transcriptomic profiling of immune cells in malignant pleural effusions identifies macrophage reprogramming associated with survival
    Aaditya Khatri, Huimin Wang, Zhicheng Ji +7
    JCI InsightPeer-reviewedCC BY 4.0Full textImmunologyPMC
  3. An FCN1+ macrophage-associated SEMA3C–NRP1 axis is linked to fibroblast reprogramming in RA-ILD
    Ruofan Su, Licheng Song, Xuxin Chen +8
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyGeneral medicineCrossrefDOAJ
  4. Reprogramming tumor-associated macrophages in breast cancer: from myeloid plasticity and tumor-promoting programs to CAR-macrophage therapy.
    Farshad Heydari, Mehdi Derakhshani, Jalal Naghinezhad
    Journal of hematology & oncologyPeer-reviewedCC BY-NC-NDFull textImmunologyEurope PMCDOAJ
  5. Complement receptor C3aR marks heterogeneous tumor‐associated macrophage states associated with improved survival in IDH ‐wildtype glioblastoma
    Marion Imara, Yosra Bedoui, Théotime Pignolet +7
    Brain PathologyPeer-reviewedCC BY-NC 4.0Full textImmunologyNeuroscienceHAL

Cite

BibTeXRIS
BibTeX
@article{ganesan2026reprogramming,
  title = {{749 Reprogramming of macrophage Fc receptor expression and antibody handling by cachexia-associated tumor secretory factors}},
  author = {Latha Ganesan and Adeoluwa Adeluola and Aki Inase and Gregory M Young and Juehui Mao and Thomas A Mace and Dwight H Owen and Christopher C Coss and Mitch A Phelps},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.0749},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.0749},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - 749 Reprogramming of macrophage Fc receptor expression and antibody handling by cachexia-associated tumor secretory factors
AU  - Latha Ganesan
AU  - Adeoluwa Adeluola
AU  - Aki Inase
AU  - Gregory M Young
AU  - Juehui Mao
AU  - Thomas A Mace
AU  - Dwight H Owen
AU  - Christopher C Coss
AU  - Mitch A Phelps
PY  - 2026
DA  - 2026/11/06
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.0749
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.0749
SN  - 2051-1426
ER  -